Home > Browse > Science > Insitro

Insitro

Insitro is an AI-powered Science tool — AI drug discovery company. Best for: Science. Pricing: Paid (GateOnAI Score: 54/100).

AI drug discovery company

PaidLive

Insitro builds a different kind of drug company that uses machine learning and large‑scale data to decode biology and create new medicines. It combines over 20 petabytes of automated cellular experiments with population‑scale genetics to construct Physical AI systems that identify causal drivers of human disease. Its Virtual Human™ platform, built on the world’s largest integrated multimodal corpus of clinical and cellular data, acts as a genetically anchored causal AI engine that maps disease onset, progression and resolution, pinpointing causal targets before candidate optimization. TherML, the company’s modality‑agnostic AI‑driven therapeutics design engine, matches the best‑fit modality—small molecules, oligonucleotides or complex biologics—to each target, shifting discovery from stochastic screening to predictive, adaptive engineering for faster, better molecule development.

Summary written from Insitro's own website on 26 Oct 2026. Check the vendor's website for current details.

Visit Insitro

How to evaluate Insitro before you buy

What GateOnAI has on record

Questions to ask the vendor

  1. Will you sign a GDPR data processing agreement (Article 28) and share your list of sub-processors?
  2. Where is our data stored and processed, and is it used to train your models?
  3. Is there a free trial or pilot, and what does the plan we need cost per user?
  4. Can we export all our data, and how is it deleted when we cancel?

Full checklist: 43 questions to ask an AI vendor · Alternatives to Insitro · Compare Insitro with PubMed

More Science Tools

May Connect With

Tools whose input/output tags match those of Insitro (the tags are assigned automatically and the connections are not tested):

Find similar tools | Browse all AI prompts